| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999663 | Urologic Oncology: Seminars and Original Investigations | 2015 | 11 Pages |
Abstract
Our results demonstrated that PDGF-B, which increased VSMCs proliferation and migration capability during angiogenesis, limited tumor growth and progression in ccRCC. Therefore, PDGF-B may be a novel and promising prognostic marker.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Wenling M.D., Lifeng M.D., Minhan M.D., Ph.D., Zhenting M.D., Ju M.D., Ph.D., Xiaona M.D., Ph.D., Xin M.D., Ph.D.,